KER-050
KER-050 KER-050: KER-050 is a therapeutic protein designed to increase red blood cell and platelet production by inhibiting the signaling of a subset of the transforming growth factor beta (TGF-ß) family of protei
Myelodysplastic Syndromes (MDS)
Updates in MDS Treatment and Research from ASCO and EHA Meetings 2022
Topic(s)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Naval Daver, MD
Dr. Naval Daver describes recent research and upcoming treatments for MDS presented at the ASCO and EHA 2022 meetings. Discover how the understanding of MDS, or Myelodysplastic Syndromes, has advanced as well as possible new treatments in this recording.